Moreover, our previous study demonstrated that either pharmacologic inhibition of mTORC1 or genetic deletion of rpS6 phosphorylation exacerbated structural and functional damage of the kidneys in Tsc1 gene-deleted mice11, suggesting that alternative strategies are needed for effective treatment of TSC-associated kidney disease. The gene discussed is TSC1; the disease is kidney disorder.